Health-Ecore

Healthcare is under pressure. Rising demand and tightening budgets call for smarter investments. By optimizing the full health value chain from vitality and prevention to diagnosis, intervention, and monitoring, we can deliver higher-quality, more affordable care.

Innovation is key. It drives better outcomes, reduces costs, and supports a healthier, more productive society. But to succeed, we must strike the right balance: broad access, affordability, and fair rewards for innovation.

The future of sustainable healthcare depends on integrated, scalable innovation. Let’s build it together.

We work closely together with private as well as public parties, aiming at sustainable impact for our customers, the healthcare field, societies and economies.

We do this by applying a holistic approach based on a clear understanding of the healthcare field on macro, meso and micro level together with a unique combination of scientific, entrepreneurial and policy expertise.

Leadership

Bringing our health ecosystem together

Involving the whole health ecosystem to focus on sustainable impact and improved health

Evidence dissemination

Making an impact through scientific publications, presentations and general outreach

Training & education

Focused on health outcomes, economics, policy and epidemiology

Strategic advice

Strategic market access

Strategic advice for market access, from early scoping and feasibility to reimbursement

Sustainable business & pricing models

Business and pricing models, price-lifecycle prediction and price negotiations

Health policy & government affairs

Alignment of stakeholders towards implementation

Health Technology Assessment

Holistic approach to HTA

Involving all stakeholders towards impactful market access trajectories

Evidence synthesis and real-world insights

Insights into the clinical value, including therapeutic dossiers and systematic literature reviews

Economic and cost-effectiveness analyses

Health-economic model development, validation and adaptation

Next-generation COVID-19 vaccine mRNA-1283 is a cost-effective investment for older and high-risk adults in the Netherlands

Simon van der Pol: Sep 21, 2026

A new cost-effectiveness analysis finds that the next-generation vaccine mRNA-1283 could prevent thousands more hospitalisations and deaths than the vaccine currently used in the Netherlands, at a price the Dutch healthcare system can justify....

Adjuvanted influenza vaccine is a cost-effective investment for older adults in the Netherlands

Susan de Braak: Jul 3, 2026

Replacing standard-dose with adjuvanted influenza vaccination in adults aged 60 and over, and in high-risk adults aged 50–59, could prevent hundreds of hospitalisations and deaths per season, at an incremental cost well within accepted Dutch...

High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands

Tanja Fens: Jun 24, 2026

Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose influenza vaccination would prevent thousands of hospitalisations each year, at a cost well within...

A Coalition of the Doing: First Steps Toward Structural Data Exchange in Healthcare

Muron van Abbema: Jun 11, 2026

Despite a growing number of data infrastructures and increasing data initiatives, secondary use of data in healthcare remains structurally underutilised. For this reason, the first roundtable on data exchange in (pharmaceutical) healthcare was...

What Delayed RSV Vaccination Is Costing the Netherlands

Simon van der Pol: Jun 2, 2026

Every winter, the Respiratory Syncytial Virus (RSV) fills hospital wards. Around 6,000 older adults are admitted with RSV infection in the Netherlands each year — a figure almost certainly conservative, given how rarely RSV diagnostics are applied...

Facilitating Investments in Obesity Prevention and Treatments

Bart Slob: May 13, 2026

Health-Ecore colleagues Bart Slob and Lisa de Jong attended the European Congress of Obesity (ECO) in Istanbul and had the chance to present their research as a poster presentation called 'Facilitating investments in obesity prevention and...

Evidence that shapes healthcare decisions

Discover our peer-reviewed studies on cost-effectiveness, budget impact, and health policy; spanning vaccines, chronic disease, medtech, AI, and emerging therapies.

Discover here

digitalhealthlink

Digital Health Link enables secure, sustainable data exchange across healthcare systems. With their LinkinPin technology, they connect fragmented health data to support better insights, improved outcomes, and more affordable care—empowering a healthier society through data-driven innovation.

Farminform-1

Farminform is a trusted data hub for the Dutch pharmaceutical sector. As an independent, not-for-profit data trust, they provide high-quality insights into medicine use and market trends, empowering healthcare providers, policymakers, and industry partners to make informed, data-driven decisions.

MedEngine, with offices in Denmark, Finland, and Sweden, is a leading Nordic partner for the pharmaceutical industry, specializing in market access, real-world evidence, medical affairs, and commercial services. Combining deep expertise in data science, market access, and digital engagement, MedEngine develops tailored solutions that support every stage of the product lifecycle—from pre-launch to late-phase lifecycle management.

PHARMA & HEALTH POLICY HUB-1

The Pharma & Health Policy Hub is a boutique consultancy with years of experience in international commercial, leadership, and policy domains within the pharmaceutical industry and healthcare. Paul van Hoof has an extensive international network within the biohpharmaceutical industry, civil society organizations, NGOs in healthcare policy, authorities, and patient advocacy groups.

SensUR Health delivers rapid, point-of-care diagnostics that empower healthcare professionals with real-time insights from blood and urine samples. Their innovative technology supports faster decisions, better outcomes, and more personalized care.

INVEST | INNOVATE | IMPLEMENT

For sustainable health impact

Our services